Lower-extremity amputation as a marker for renal and cardiovascular events and mortality in patients with long standing type 1 diabetes

Abstract

BackgroundWe evaluated the risks of renal and cardiovascular complications, and mortality associated with lower extremity amputation (LEA) in patients with type 1 diabetes.MethodsWe studied two cohorts of people with long standing type 1 diabetes: GENEDIAB (n = 456) and GENESIS (n = 611). Subsets of the cohorts (n = 260, n = 544) were followed for 9 and 5 years, respectively. Outcomes were the incidence of end stage renal disease (ESRD), myocardial infarction, stroke and mortality during follow-up. Analyses were performed in pooled cohorts.ResultsThe prevalence of LEA at baseline was 9.3 % (n = 99). A positive history of LEA was associated with the baseline prevalence of established (OR 4.50, 95 % CI 2.33–8.91, p < 0.0001) and advanced diabetic nephropathy (OR 5.50, 95 % CI 2.89–10.78, p < 0.0001), ESRD (OR 2.86, 95 % CI 1.43–5.50, p = 0.004), myocardial infarction (OR 3.25, 95 % CI 1.68–6.15, p = 0.0006) and stroke (OR 3.88, 95 % CI 1.67–8.72, p = 0.002, adjusted for sex, age, and cohort membership). A positive history of LEA at baseline was associated with the incidence during follow-up of ESRD (HR 2.69, 95 % CI 1.17–6.20, p = 0.02), and myocardial infarction (HR 3.53, 95 % CI 1.79–6.97, p = 0.0001). History of LEA was also associated with increased risk for all-cause (HR 3.55, 95 % CI 2.05–6.16, p < 0.0001), cardiovascular (HR 3.30, 95 % CI 1.36–8.02, p = 0.008), infectious disease (HR 5.18, 95 % CI 1.13–23.84, p = 0.03) and other-cause mortality (HR 2.81, 95 % CI 1.09–7.26, p = 0.03). History of LEA at baseline was associated with a 40 % reduction in the duration of survival in the subset of patients who died during follow-up. Population attributable risk of the history of LEA at baseline for total mortality during follow-up was 0.31.ConclusionsPatients with LEA have a higher risk of ESRD, myocardial infarction and cardiovascular and non-cardiovascular mortality. Our results highlight the importance of LEA as a key-predictor for major vascular events and premature death in type 1 diabetic patients.Electronic supplementary materialThe online version of this article (doi:10.1186/s12933-015-0322-0) contains supplementary material, which is available to authorized users.

Lower extremity arterial disease in patients with diabetes: a contemporary narrative review

“…LEAD has clearly been identified as a common manifestation of atherosclerosis of the large vessels [ 29 ]. However, recent studies provided evidence for the implication of microvascular dysfunction in the pathogenesis of macrovascular disease including LEAD [ 30 – 32 ]. An Italian study has shown microvascular histological changes including expansion of the basal membrane and a reduced capillary density in neuro-ischaemic diabetic feet with revascularization requirement [ 32 ].…”

Major Adverse Cardiovascular Events Following Simultaneous Pancreas and Kidney Transplantation in the United Kingdom

“…These risk factors are surrogates for prevalent vascular disease and are considered markers of "diabetes severity." They have been shown to be potent risk factors for CVD events in other clinical contexts (26)(27)(28)(29).…”

Burden of cardiovascular risk factors and disease among patients with type 1 diabetes: results of the Australian National Diabetes Audit (ANDA)

“…The finding that diabetic retinopathy and declining renal function was associated with peripheral vascular disease was not surprising and may relate to shared risk factors [ 64 – 66 ]. In our cross-sectional study, microvascular complications such as retinopathy or nephropathy provided an indication of long term risk factor exposure, but cohort studies have suggested PVD may also predict cardiovascular outcomes and end stage kidney disease [ 64 , 67 ]. Further, the negative association between renal function and stroke that we observed is in keeping with studies among the general population [ 68 – 71 ].…”